Gateway-To-Sobriety-Soft-Layout-mgc

CALL TODAY With fast turnaround time, easy, convenient web-based interface and clear and understandable reporting we provide you the opportunity of better patient care. How Gateway To Sobriety Can Help You Our services are voluntary, and while we provide a structured nvironment for you to regain strength in battling your addiction, our main purpose is supporting treatment and recovery. While your addiction is the primary focus of all staff members, we also analyze all aspects of your life, such as your lifestyle and environment, to t y to get to th root f the issue.

7445 Park Place Blvd. Houston, TX 77087

832-767-1560

www.gatewaysobriety.com

832-767-1560

www.gatewaysobriety.com

Inter

________________

iew 1

________________

Inter

________________

iew 2

________________

832-767-1560

www.gatewaysobriety.com

7445 Park Place Boulevard Houston, TX 77087

OPIATE + OPIOID ADDICITON What is the difference between Opiates and Opioids?

OPIATES

OPIOIDS

A Natural Pain RemedIES

SYNTHETIC PAIN MEDICATIONS

VS.

Opium

Oxycodone

Thebaine

Hydrocodone

Morphine

Oxymorphone

Codeine

Hydromorphone

Heroin

What Medications Treat Opiate & Opioid Addiction?

Naltrexone

These medications act directly upon the opioid receptors; more specically the mu receptors. Because the effects of these medications vary at the receptor level, there can be different clinical effects during treatment.

ReVia | Depade | Vivitrol

Methadone Dolophine

Buprenorphine Suboxone | Subutex

A FULL AGONIST binds to the receptor and activates it by changing its shape - inducing a full receptor response.

A PARTIAL AGONIST binds to the receptor and activates it with a smaller shape change in the receptor that includes a partial receptor response.

Inter

________________

iew 3

________________

Two-P

ge Ad

www.gatewaysobriety.com

POWER OF ATTRACTION

Recent research indicates that magnetic stimulation to the brain may work to curb addictive tendencies in humans, according to research covered in a recent Smithsonian.com article. Researchers tested transcranial magnetic stimulation (TMS) in humans in an attempt to curb cocaine addiction. The treatment used magnets on cocaine addicts for ve consecutive days, followed by once-a-week treatments for three weeks. The number of participants was only 29, but the ndings were still encouraging: Of the 13 people who received an all-TMS protocol, 10 exhibited what researchers determined to be substantial improvement in controlling cocaine cravings. “I have met with these patients, I have seen them, I have seen their families,” says Antonello Bonci, a neuropsychopharmacologist and National Institute on Drugs researcher who co-authored the study, to Smithsonian.com. “They are alive, they are well . . . something has clearly happened to these people.” Researchers Think Magnets Can Help With Drug Addiction Impulses

Magnetic Stimulation

The Mayo Clinic denes TMS as “a noninvasive procedure that uses magnetic elds to stimulate nerve cells in the brain to improve symptoms of depression. TMS is typically used when other depression treatment hasn’t been effective.” It works through an electromagnetic coil that is placed directly on a person’s head, near the forehead. The electromagnetic simulation painlessly delivers a magnetic pulse that stimulates nerves in the PFC—the part of the brain also involved with mood control and depression, as well as addiction. “We know that addictive drugs change many, many brain regions, as many as 90 or more, and these regions are organized into overlapping circuits. We have no idea how, given this enormous complexity, just shutting down or tuning up one single region can produce such profound effects,” Bonci says, adding that drug addicts “are often unable to switch from a counterproductive behavior to another, more benecial, one. They get stuck in repetitive, compulsive behaviors, such as using drugs.” Bonci tells Smithsonian.com that he is currently in the process of launching a larger, placebo-controlled, double-blind study of cocaine addicts. “This is a pilot study—we have a lot of work to do,” says Bonci. “I think that we will know, in just a few years, if this will become an accepted treatment.”

Many Uses For TMS

Researchers are looking into the potential of TMS as an effective treatment for a number of ailments. The National Center for Biotechnology Information (NCBI) researchers have studied how TMS can be used for obsessive-compulsive disorder, Parkinson’s disease, and epilepsy. The Journal of Headache and Pain published work studying the effects of TMS researchers studying TMS treatment for alcohol craving suppression and addictive behaviors. NCBI also published a study on TMS and binge eating disorder and comorbid depression, and The Journal of Clinical Psychiatry published a story on the effects of high-frequency repetitive TMS stimulation for decreasing cigarette smoking. Research on the effects of TMS aims to not only explore better ways to treat illness, but also to better understand TMS. “Though the biology of why TMS works isn't completely understood, the stimulation appears to affect how this part of the brain is working,” writes Mayo Clinic Staff in their overview of TMS. One of the primary reasons for pursuing TMS as a treatment alternative is that, unlike other medications, it doesn't have signicant side-effects. “TMS is well-tolerated and associated with few side-effects and only a small percentage of patients discontinue treatment because of these,” write Johns Hopkins Medicine Psychiatry and Behavioral Sciences researchers. treatment on migraines. The journals of Neuroscience Letters and Neuroscience & Biobehavioral Reviews published work by

“We know that addictive drugs change many, many brain regions, as many as 90 or more, and these regions are organized into overlapping circuits. We have no idea how, given this enormous complexity, just shutting down or tuning up one single region can produce such profound effects.”

— Antonello Bonci Neuropsychopharmacologist Director of National Institute on Drug Abuse’s Intramural Research Program

Scientists search for the ‘Holy Grail’

On October 24, 2018... President Trump signed a new, bipartisan bill to combat the opioid addiction epidemic. Politicians are hailing it as a major step forward, while addiction and treatment experts say it falls far short of

A package of more than 70 bills introduced targeting the opioid crisis, the Support for Patients & Communities Act:

• Reauthorizes funding from the Cures Act, which put $500 million a year toward the opioid crisis, and makes some policy changes intended to give states more • Creates a grant program for “Comprehensive Opioid Recovery Centers,” which will attempt to serve the addiction treatment and recovery needs of their communities (in part by using what’s known as an ECHO model). • Removes restrictions on medications for opioid addiction, allowing more types of health care practitioners to prescribe the drugs.

• Expands an existing program

• Advances new initiatives to educate and raise awareness about proper pain treatment among health care providers. • Attempts to improve coordination between different federal agencies to stop illicit drugs like fentanyl at the border, and gives agencies more tools to improve detection and testing at border checks. • Increases penalties for drug manufacturers and distributors related to the over-prescribing of opioids.

responders, such as police and

naloxone, a medication that reverses opioid overdoses.

• Allows federal agencies to pursue more research projects related to addiction and pain. • Makes several changes to Medicare and Medicaid to attempt to limit the over-prescription of opioid painkillers within the programs and expand access to addiction treatment, including lifting some of the current restrictions that make it harder for Medicare and Medicaid to pay for addiction treatment.

It also authorizes HHS to develop grants to support people who are in recovery transition to independent living and jobs, as well as develop a pilot program to provide temporary housing for those recovering from substance abuse. of the bill provides measures to prevent synthetic opioids like fentanyl from entering the U.S. According to the Centers for Disease Control, total opioid deaths did not increase in 2017, but deaths due to fentanyl overdoses did. Data shows the drug, which is about 50 times more potent than heroin, caused nearly 30,000 fatal overdoses last year. access to medication-assisted treatment. It removes the cap on the number of patients to whom drugs like buprenorphine, a drug cravings and easing withdrawal, from 100 to 275, and expands a grant program allowing medication-assisted treatments.

strengthen the federal government’s response to the opioid crisis,” Sen. Rob Portman (R-OH), who helped put together the legislation, said in a statement after the Senate vote. “Importantly, this bill will increase access to long-term treatment and recovery while also like fentanyl from being shipped into the United States through our own Postal Service.” On the other side of the debate, Leana Wen, M.D., the former health commissioner of Baltimore (and incoming president of Planned Parenthood), said that the legislation “is simply tinkering around the edges.” Daniel Raymond, director of policy and planning for the Harm a bad thing, but I do think to some degree it’s a political document,” Raymond told the Washington Post. “When you drill down into it, it’s not that there aren’t good ideas, but it doesn’t reach the level of, this is what our nation needs right now.” and Mental Health Services Administration (SAMHSA) to allow organizations to develop opioid recovery centers in a community. It also requires the Department of Health and Human Services to determine best practices and then create a grant program implementing those policies or procedures, such as the use of recovery coaches, which has

Trial evaluated effectiveness for common injuries

Four Groups of Patients The patients were randomly assigned to one of four groups. One group received a pill for their acute pain that contained a combination of ibu- profen and acetaminophen, the ingredients in Advil and Tylenol. The other groups were given a pill for their pain that contained a prescription opioid as well as acetaminophen, either oxyco- done and acetaminophen (Percocet), hydroco- done and acetaminophen (Vicodin), or codeine and acetaminophen (Tylenol No. 3). All the patients were asked to rate their pain immediately before taking the pain medication and again both one and two hours afterward (before they left the emergency department). The assessments were done using an 11-point scale (0 = no pain; 10 = worst possible pain). The study found that the intensity of pain was similar among all four groups before they took the medication, with a mean score of 8.7 on the scale. The pain then declined over time in all

As the over prescribing of opioid pain medications has become a major public health concern, health care providers have been paying more attention to over-the count- er-drugs that could be used instead, without the risk of addiction. A recent study published in the Journal of the American Medical Association (JAMA) has confirmed that OTC meds ibuprofen and acet- aminophen are just as effective as prescription opioids at reducing acute pain caused by com- mon injuries.It is one of the few “real world” studies that has made the comparison. A team of researchers led by Andrew Chang, M.D. of Albany Medical College, studied 411 patients (aged 21 to 64) who had sought med- ical care at two urban emergency departments after having sprained, strained or broken an arm or leg. (About 20 percent of the patients had fractures.)

individuals can become addicted even after only taking opioid pain meds for a few days. One study found that one in five people given a 10-day supply of opioid painkillers became long-term users. More M.D. Education Needed Don Teater, M.D., medical adviser of the non-profit National Safety Council, says doctors need more education to understand the draw- backs of prescribing opioids. “Doctors get a lot of training in the physical aspects of health, but not the mental aspects,” says Teater, a family physician in North Carolina whose practice focuses on treatment of pain and the treatment of opioid use disorder. “We don’t get training in addiction. Often, a doctor will start a patient on opioid pain med- ication and continue it for awhile. Then if the doctor feels the patient is asking for too much medication, the doctor will cut them off, and abandon them. There needs to be a greater understanding of the emotional component to pain. We also need to have a better under- standing of the disease of addiction.” According to a white paper from the Council, there is little evidence that opioids are helpful when used for chronic pain.

four groups – and by similar levels: 4.3 points in the ibuprofen/acetaminophen group, 4.4 points in the oxycodone/acetaminophen group, 3.5 in the hydrocodone/acetaminophen group and 3.9 in the codeine/acetaminophen group. The researchers said the major limitation of the study is that it had the patients assess their pain only while they were in the emergency department. The study did not evaluate how the ibuprofen/acetaminophen combination would work in comparison to opioids once the patients went home. Also, the participants had a specific type of acute pain – from sprained or broken arms and legs. “Preventing new patients from becoming addicted to opioids may have a greater effect on the opioid epidemic than providing sus- tained treatment to patients already addicted to opioids, in whom it may take many years to achieve recovery,” Demetrio Kyriacou, M.D., a senior editor at JAMA and a professor of emer- gency medicine at Northwestern University, wrote in an accompanying editorial. Yet, as Kyriacou also acknowledges, “stemming the opioid addiction crisis will … require reex- amination of the long-standing assumptions that opioids are superior to

non-opioids in most clinical situations requiring man- agement of moderate to severe pain.” Studies have shown that nearly one-third of adult patients seeking care at U.S. hospital emergency departments are given prescriptions for opioid painkillers, even if their visit was not pain-relat- ed. That is a dangerous practice, since some

“In fact, some evidence shows they may be detri- mental and increase risk of addiction and premature death,” the paper says.

There is little evidence that opioids are helpful when used for chronic pain.

www.gatewaysobriety.com TO LEARN HOW GATEWAY TO SOBRIETY CAN HELP YOU - VISIT OUR WEBSITE

7445 Park Place Blvd. Houston, TX 77087

832-767-1560

Inter

________________

iew 4

________________

7445 Park Place Blvd. Houston, TX 77087 832-767-1560

www.gatewaysobriety.com

Inter

________________

iew 5

________________

Inter

________________

iew 6

________________

FROM While your addiction is the primary focus of all staffmembers here at Gateway to Sobriety - we also analyze all aspects of your life, such as your lifestyle and environment, to try to get to the root of the issue.

832-767-1560

7445 Park Place Blvd. − Houston, TX 77087

www.gatewaysobriety.com

ADDICTION

To learn more about our programs & services call or Visit Us Online 832-767-1560 www.GatewaySobriety.com

Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 Page 10 Page 11 Page 12 Page 13 Page 14 Page 15 Page 16 Page 17 Page 18 Page 19 Page 20 Page 21 Page 22 Page 23 Page 24 Page 25 Page 26 Page 27 Page 28 Page 29 Page 30 Page 31 Page 32 Page 33 Page 34 Page 35 Page 36

Powered by